|
What is Gadolinium? Gadolinium is a paramagnetic metal ion which, because move differently within a magnetic field has made gadolinium useful for magnetic resonance imaging (MRI). Since December 2006, however, the FDA has investigated reports of nephrogenic systemic fibrosis (NSF) in patients who received gadolinium-based contrast agents (GBCAs) to help define risk factors for NSF.
What is NSF Nephrogenic Systemic Fibrosis? Nephrogenic Systemic Fibrosis was first described in the medical literature in 2000. The first case of NSF was identified in 1997. The cause of Nephrogenic Systemic Fibrosis is unknown but it has been reported only in patients who have severe kidney disease. Nephrogenic Systemic Fibrosis causes fibrosis of the skin and connective tissues throughout the body. Patients develop skin thickening that may prevent bending and extending joints, resulting in decreased mobility of joints. NSF usually starts in the lower extremities. Fibrosis can also develop in the diaphragm, muscles in the thigh and lower abdomen, and lung vessels.
Over time, NSF becomes worse and can cause death.
If you have been diagnosed with NSF or Nephrogenic Systemic Fibrosis you should contact an attorney. For a free case review fill out the form below. An attorney will review your form any may contact you to discuss your claim.
Injured Person Information:
Accident / Injury Information:
Case Description*
Please explain exactly what happened, trying to state
as thoroughly as possible who you believe was responsible
and why you believe that person was negligent:
|
Please explain the full extent of the victims injuries:
|
Comments / Additional Information
Is there anything else that would assist us in
understanding the facts of your case?
|
|